Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers
Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This is a prospective, single site, randomized, double masked, comparator-controlled study
designed to evaluate the efficacy of lifitegrast ophthalmic solution 5% in treating the
symptoms of dry eye in soft contact lens wearers as compared to control. We hypothesize that
there will be a significant improvement in dry eye symptoms in contact lens wearers using
lifitegrast as compared to those being treated with control (lifitegrast vehicle).